FORT LAUDERDALE, Fla. & TEL AVIV, Israel, July 23, 2026
Momentis Surgical has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the multiport configuration of its Anovo® Surgical System, marking a significant advancement in robotic-assisted minimally invasive surgery. The latest regulatory milestone expands the platform beyond its previously cleared natural orifice and single-port indications, making Anovo the first robotic surgical platform capable of supporting natural orifice, single-port, and multiport procedures on a single flexible robotic system. The clearance provides surgeons with greater procedural flexibility while enabling hospitals and ambulatory surgery centers to perform multiple minimally invasive surgical approaches without investing in multiple robotic platforms. This achievement strengthens Momentis Surgical’s position in the rapidly evolving robotic surgery and medical technology market while addressing growing demand for adaptable, cost-efficient surgical systems.
FDA Clearance Expands Surgical Flexibility with Three Access Approaches
The newly cleared multiport configuration allows surgeons to utilize Anovo’s proprietary internally articulated robotic instruments in conventional multiport procedures while leveraging the same robotic platform already cleared for natural orifice and single-port surgery. Unlike traditional robotic systems that rely on rigid, straight instruments, the Anovo Surgical System incorporates humanoid-inspired shoulder, elbow, and wrist-like articulation, enabling 360-degree instrument dexterity inside the patient while minimizing external robotic arm movement. This design reduces the likelihood of robotic arm collisions, improves surgical maneuverability, and maintains a compact operating footprint. The expanded indication enables general surgeons to choose between single-site and multiport techniques for ventral hernia repair, while gynecologic surgeons can now perform procedures using transvaginal, single-site, or multiport approaches on the same robotic platform, providing greater flexibility based on individual patient needs.
Flexible Robotic Platform Improves Hospital Efficiency
The FDA clearance significantly enhances the modularity of the Anovo Surgical System, allowing healthcare providers to support multiple minimally invasive surgical techniques without purchasing separate robotic systems for different procedures. The platform’s compact architecture, simplified workflow, and reduced capital investment requirements are designed to make robotic-assisted surgery more accessible for hospitals and ambulatory surgery centers. By shifting the articulation point inside the patient rather than relying on bulky external robotic arms, the platform delivers enhanced surgical precision while maintaining efficient operating room ergonomics. Company leadership emphasized that the future of robotic surgery lies in offering surgeons the freedom to select the most appropriate surgical access approach rather than limiting them to a single technique. This flexible design supports broader clinical adoption while improving workflow efficiency across multiple surgical specialties.
Advertisement
Momentis Advances Innovation in Robotic Surgery
The latest FDA 510(k) clearance builds upon a series of regulatory achievements for Momentis Surgical, including the first FDA De Novo authorization for a robotic transvaginal surgical system, subsequent approvals supporting single-site ventral hernia repair, and the integration of robotic camera control into the company’s expanding surgical platform. Commercial adoption of the second-generation Anovo platform has demonstrated increasing acceptance among robotic surgeons, with many transitioning routine benign gynecologic procedures from legacy robotic systems to the flexible platform. By combining natural orifice, single-port, and multiport surgery into one unified robotic ecosystem, Momentis is advancing the evolution of minimally invasive surgery while expanding access to innovative robotic technology. As healthcare providers continue seeking solutions that improve clinical efficiency, procedural versatility, and economic value, the Anovo Surgical System represents an important step toward the next generation of robotic-assisted surgical care.
Source: Momentis Surgical press release
